MedTrace Logo

Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu Language

NCT04873960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-06-21

No results posted yet for this study

Summary

Osteopenia is a clinical term to define the declined Bone Mineral Density (BMD) as per the normal reference values but not low enough to meet osteoporotic diagnostic criteria. A Dual-energy x-ray absorptiometry (DXA) bone scan is used to diagnose decreased BMD. Osteopenia is, as described by the World Health Organization (WHO), a score ranging from -1 to -2.5, whereas Osteoporosis is diagnosed with values less than - 2.5. The risk of a decrease in BMD doubles as a woman goes into Menopause.

The objective of this study will be to determine the effects of Kinect-based virtual reality training on BMD, fracture risk, physical function and Quality of life in postmenopausal women with Osteopenia. The aim of the present study is to translate the ECOS-16 Questionnaire into Urdu Language along with validation of the translated versions by evaluating its validity and reliability in the Postmenopausal women of Pakistan with Osteopenia or Osteoporosis and understanding Urdu Language. No such study has been previously conducted in the Pakistan region which translates the specific questionnaire and follows the proper cross-culture adaptation protocol.

Conditions

  • Postmenopausal Osteopenia
  • Quality of Life
  • Validity
  • Reliability
  • Postmenopausal Osteoporosis

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Syed Shakil Ur Rehman, PhD · Riphah International University

  • Saima Riaz, PhD* · Riphah International University

Eligibility

Min Age
48 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-03-25
Completion
2022-05-25

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04873960 on ClinicalTrials.gov